Back
Novo Nordisk A/S Quote, Financials, Valuation and Earnings
Earn Your Weekly "Paycheck" with Chuck's Secret Income Strategy!
Act now for your path to extra income!
Buy
67
NONOF
Novo Nordisk A/S
Last Price:
124.64
Seasonality Move:
4.9%
7 Day Trial
ALL ACCESS PASS
$
7
Master the Market: The Formula for a 96.3% Win Rate Revealed!
Act now!Novo Nordisk A/S Price Quote
$124.64
Novo Nordisk A/S Key Stats
Buy
67
Novo Nordisk A/S (NONOF)
is a Buy
Day range:
$123.30 - $130.00
52-week range:
$74.70 - $140.32
Dividend yield:
1.1%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0%
Volume:
2.1K
Avg. volume:
22.2K
1-year change:
50.76%
Market cap:
$557.6B
Revenue:
$25.1B
EPS:
$3.8
How Much Does Novo Nordisk A/S Make?
-
How Much Are Novo Nordisk A/S's Sales Annually?
NONOF Revenues are $25.1B -
How Much Profit Does Novo Nordisk A/S's Make A Year?
NONOF net income is $7.9B
Is Novo Nordisk A/S Growing As A Company?
-
What Is Novo Nordisk A/S's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.34% -
What Is Novo Nordisk A/S's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0.5%
Novo Nordisk A/S Stock Price Performance
-
Did Novo Nordisk A/S Stock Go Up Last Month?
Novo Nordisk A/S share price went down by -3.68% last month -
Did NONOF's Share Price Rise Over The Last Year?
NONOF share price rose by 50.76% over the past 1 year
What Is Novo Nordisk A/S 52-Week High & Low?
-
What Is Novo Nordisk A/S’s 52-Week High Share Price?
Novo Nordisk A/S has traded as high as $140.32 over the past 52 weeks -
What Is Novo Nordisk A/S’s 52-Week Low Share Price?
Novo Nordisk A/S has traded as low as $74.70 over the past 52 weeks
Novo Nordisk A/S Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Novo Nordisk A/S?
-
How Much Debt Does Novo Nordisk A/S Have?
Total long term debt quarterly is $3.8B -
How Much Cash Does Novo Nordisk A/S Have?
Cash and short term investments quarterly total is $5.3B -
What Is Novo Nordisk A/S’s Book Value Per Share?
Book value per share is 2.95
Is Novo Nordisk A/S Cash Flow Positive?
-
What Is NONOF Cash Flow From Operations?
Cash flow from operations (TTM) is $12.9B -
What Is Novo Nordisk A/S’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$8B -
What Is Novo Nordisk A/S’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$5B
Novo Nordisk A/S Return On Invested Capital
-
Is Management Doing A Good Job?
NONOF return on invested capital is 63.4% -
What Is Novo Nordisk A/S Return On Assets?
ROA measures how assets are converting to revenues and is 27.17% -
What Is NONOF Return On Equity?
ROE is a measure of profitability and is 82.75%
Novo Nordisk A/S Earnings Date & Stock Price
-
What Is Novo Nordisk A/S's Stock Price Today?
A single share of NONOF can be purchased today for 124.64 -
What Is Novo Nordisk A/S’s Stock Symbol?
Novo Nordisk A/S trades on the otcm under the ticker symbol: NONOF -
When Is Novo Nordisk A/S’s Next Earnings Date?
The next quarterly earnings date for Novo Nordisk A/S is scheduled on May 2, 2024 -
When Is NONOF's next ex-dividend date?
Novo Nordisk A/S's next ex-dividend date is March 22, 2024 -
How To Buy Novo Nordisk A/S Stock?
You can buy Novo Nordisk A/S shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Novo Nordisk A/S Competitors
-
Who Are Novo Nordisk A/S's Competitors?
Below is a list of companies who compete with Novo Nordisk A/S or are related in some way:
Novo Nordisk A/S Dividend Yield
-
What Is NONOF Dividend Yield?
Novo Nordisk A/S’s dividend yield currently is 1.1% -
What Is Novo Nordisk A/S’s Payout Ratio?
Novo Nordisk A/S’s payout ratio is 42.26% -
When Did Novo Nordisk A/S Last Pay A Dividend?
The latest dividend pay date is April 28, 2024 -
What Is Novo Nordisk A/S’s Dividend Per Share?
Novo Nordisk A/S pays a dividend of $0.00 per share
Novo Nordisk A/S Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 50.35% | 0% |
| Revenue: | 34.34% | 7.57% |
Analyst Recommendations
| Buy Recommendations: | 0 |
|---|---|
| Hold Recommendations: | 1 |
| Sell Recommendations: | 0 |
| Price Target: | 95.19 |
| Downside from Last Price: | -23.62% |